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Abstract
Background: This study aimed to compare one state-of-the-art deep learning method and four classical machine
learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer (NSCLC) from 18F-FDG
PET/CT images. Another objective was to compare the discriminative power of the recently popular PET/CT texture
features with the widely used diagnostic features such as tumor size, CT value, SUV, image contrast, and intensity
standard deviation. The four classical machine learning methods included random forests, support vector machines,
adaptive boosting, and artificial neural network. The deep learning method was the convolutional neural networks (CNN).
The five methods were evaluated using 1397 lymph nodes collected from PET/CT images of 168 patients, with
corresponding pathology analysis results as gold standard. The comparison was conducted using 10 times 10-fold cross-
validation based on the criterion of sensitivity, specificity, accuracy (ACC), and area under the ROC curve (AUC). For each
classical method, different input features were compared to select the optimal feature set. Based on the optimal feature
set, the classical methods were compared with CNN, as well as with human doctors from our institute.
Results: For the classical methods, the diagnostic features resulted in 81~85% ACC and 0.87~0.92 AUC, which were
significantly higher than the results of texture features. CNN’s sensitivity, specificity, ACC, and AUC were 84, 88, 86, and
0.91, respectively. There was no significant difference between the results of CNN and the best classical method. The
sensitivity, specificity, and ACC of human doctors were 73, 90, and 82, respectively. All the five machine learning
methods had higher sensitivities but lower specificities than human doctors.
Conclusions: The present study shows that the performance of CNN is not significantly different from the best classical
methods and human doctors for classifying mediastinal lymph node metastasis of NSCLC from PET/CT images. Because
CNN does not need tumor segmentation or feature calculation, it is more convenient and more objective than the
classical methods. However, CNN does not make use of the import diagnostic features, which have been proved more
discriminative than the texture features for classifying small-sized lymph nodes. Therefore, incorporating the diagnostic
features into CNN is a promising direction for future research.
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Background
In recent years, diagnosis of non-small cell lung cancer
(NSCLC) from PET/CT images became a popular
research topic [1–4]. Many studies focused on assessing
the efficacy of 18F-FDG PET/CT for diagnosing medias-
tinal lymph node metastasis [5–12], whereas the judg-
ment of metastasis was mostly based on thresholding
the image features such as maximum short diameter,
maximum standardized uptake value (SUVmax), or mean
standardized uptake value (SUVmean). Due to the limited
number of image features and the simplicity of feature
thresholding strategy, the diagnostic power of PET/CT
might not have been fully explored. According to a
recent summary [13] of the past 10 years for mediastinal
lymph node NSCLC diagnosis using 18F-FDG PET/CT,
the median sensitivity was only 62%, which means a
large portion of metastasis were false-negatively judged.
To improve the diagnosis sensitivity of mediastinal
lymph node NSCLC, more sophisticated classification
strategy is needed and computerized machine learning
algorithms could be of help.
Computer-aided diagnosis (CAD) methods of medical
images have been developed for decades [14], but many
methods were designed for imaging modalities other than
nuclear medicine, such as X-ray, CT, MR, and ultrasound.
It was not until the recent 5 years that PET/CT texture
features attracted increased research attention for tumor
diagnosis [15–18], radiotherapy response characterization
[19], and treatment outcome prediction [20]. Texture
features reflect the heterogeneity of tumor uptake which
could be helpful for differential diagnosis. However, due to
the influence of various factors including imaging proto-
col, lesion size, and image processing, the effectiveness of
PET/CT texture features is still under argumentation [21],
and standardization of texture feature calculation is highly
required [22]. For mediastinal lymph node NSCLC,
further study is needed to evaluate the diagnostic ability of
PET/CT texture features.
Along with the development of computer hardware
and the growth of medical image data, the applications
of deep learning technique for medical image CAD be-
came a hot research direction. This technique uses deep
artificial neural networks to learn the image appearance
patterns of interested objects based on a large training
data set. Deep learning has been reported to significantly
outperform classical machine learning methods for
object detection and classification and has been increas-
ingly used for medical image analysis [23]. So far, the
applications of deep learning for medical images include
the detection and segmentation of lesions from CT
images [24–26], colonoscopy videos [27], and histopath-
ology images [28, 29], but the applications on tumor
diagnosis are limited [30]. Compared to classical
machine learning methods, deep learning method does
not require segmentation of tumor, it simplifies the ana-
lysis procedure and avoids subjective user bias. To the
extent of our knowledge, there has not been any study
using deep learning technique for the classification of me-
diastinal lymph node NSCLC from FDG PET/CT images.
Based on the above considerations, this study aimed to
compare the performance of multiple machine learning
methods for classifying mediastinal lymph node NSCLC
from PET/CT images. The evaluated methods included
both classical feature-based methods and the state-of-the-
art deep learning approach. For the classical methods, the
texture features were compared with the features used by
human doctors for clinical diagnosis, such as tumor size,
CT value, SUV, image contrast, and intensity standard
deviation. The machine learning methods were also com-
pared with human doctors, so as to evaluate the value of
computerized methods for classifying mediastinal lymph
node NSCLC from FDG PET/CT images.
Methods
Data resources
The study was approved by our institutional research
ethics board. This was a retrospective per-node study.
18F-FDG PET/CT images of 168 patients were retrieved
from our hospital database within the period from June
2009 to September 2014. Lobectomy combined with
systematic hilar and mediastinal lymph node dissection
was performed in our institute. The locations of re-
moved lymph nodes were tracked on a per-station basis.
We removed the lymph nodes located on groups 1, 2R,
3, 4R, 7, 8, and 9R in the right lung and groups 4L, 5, 6,
7, 8, and 9L in the left lung, and put the lymph nodes
from the same nodal station into one sampling bag.
Pathological diagnosis of each specimen bag was made
by an oncological pathologist with 18 years of experience
based on hematoxylin-eosin staining. From the 168
patients, 1397 lymph nodes were confirmed cancerous
by pathology, and the number of negative and positive
samples were 1270 and 127, respectively. Detailed infor-
mation is listed in Table 1.
The PET/CT scans were applied within 1 week before
surgery. All patients fasted for more than 4 h before the
scan to keep the blood glucose below 6.0 mmol/L. The
patients were intravenously injected with 300–400 MBq
18F-FDG of ≥97% radiochemical purity synthesized by
the GE Minitracer cyclotron and Tracer Lab FX-FDG
Table 1 Patient and lymph node characteristic
Patients number (male/female/total) 91/77/168
Patient ages (min/max/median) 38/81/61
Lymph nodes number
(benign/malignant/total)
1270/127/1397
Lymph nodes short axis diameter
(≤2/≤4/≤7/≤10/>10 mm)
306/816/246/23/6
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synthesizer. After 1-h resting following the injection,
patients were scanned by the GE Discovery ST PET-CT
scanner. Whole-body CT scan was performed under
shallow breathing status. The CT scanner settings
were 120 kV, 140 mA, 0.5 s per rotation, 1.25:1 pitch,
3.75-mm slice thickness, 1.37-mm in-plane spatial
resolution, and 20–30-s scan time. PET scan was performed
in a 3D acquisition mode also under shallow breathing
status. Six or seven bed positions were scanned for each
patient with 2.5-min emission time per bed position. PET
images were reconstructed by iterative algorithm, using CT
image for attenuation correction.
Based on the PET/CT images, diagnosis of lymph
node metastasis status (positive or negative) was made
by four doctors from our institute, two of whom with
over 10 years experience. Final consensus was reached
after the discussion of all doctors. The doctors made
their diagnosis based on several factors including max-
imum short diameter, maximum standardized uptake
value (SUVmax), mean standardized uptake value (SUVmean),
visual contrast between the tumor, and its surrounding
tissues in the CT image, as well as the location in the lymph
node map [31].
Machine learning methods
This study compared four mainstream classical machine
learning methods and one deep learning method. The
classical methods included random forest (RF), support
vector machines (SVM), adaptive boosting (AdaBoost),
and back-propagation artificial neural network
(BP-ANN). We refer the readers to [32] for detailed
introduction of the classical methods. The four classical
methods were implemented using the functions of
MATLAB R2014b. This study used 10 times 10-fold
cross-validation to evaluate the machine learning
methods. For each of the cross-validations, the optimal
parameters of each method were determined based on
the nine folds of training samples, via grid search in the
parameter space. Therefore, each cross-validation might
have slightly different optimal parameters, and the aver-
age optimal values are reported here. The random forest
contained 100 decision trees on average. The depth of
each tree was controlled by a minimum leaf size of 1,
the number of features used for each decision split was
set to the square root of the total feature number. SVM
used a Gaussian radial basis function as the kernel func-
tion, and the sequential minimal optimization method to
find the separating hyperplane, its average kernel size
was 2.0. AdaBoost used shallow decision trees as the
weak classifiers, it included 300 shallow decision trees
with a maximum split number equal to 1, the average
learning rate was 0.1. ANN used two hidden layers with
50 and 26 neurons for the first and second layer,
respectively, there were 1000 epochs, and the average
learning rate was 0.04.
The deep learning method was the convolutional
neural network [33], which is a deep neural network
dedicated for image classification, it is also named the
ConvNets in some literatures. CNN has been proved to
significantly outperform the classical machine learning
methods for natural image classification. Unlike the clas-
sical methods which take the feature vectors as input,
CNN takes an image patch of n × n pixels as input. CNN
performs classification according to the appearance of
the image patch; it learns the patterns of patch appear-
ance from a large amount of training patches. The
outputs of CNN are the scores for different classes, and
the class with the highest score is deemed as the classifi-
cation result. For our application, the input of CNN is a
patch around the lymph node, the outputs are two
scores of being benign and malignant.
The architecture of CNN mimics the structure of
animal visual cortex. The input image patch is firstly
passed to several consecutive layers that convolute and
downsample the patch, followed by a flattening layer
which stretches the patch into a feature vector. After the
flattening layer, the subsequent layers (namely the fully
connected layers and the softmax layer) convert the fea-
ture vector into the output scores. In recent years, several
improved CNN architectures have been proposed, but
their overall architecture kept similar. This study used the
well-known AlexNet [34] architecture implemented using
the Keras library for Python. To avoid overfitting to our
data, the number of AlexNet layers was reduced to five.
Our CNN also incorporated L2 normalization, ReLU acti-
vation function, dropout regularization, categorical cross
entropy loss function, and Adadelta learning method. The
choice of CNN architecture will be further explained in
the “Discussion” section.
For both training and testing stages, the inputs of
CNN were six axial image patches cropped from the CT
and PET SUV images. The six patches included three
patches for each image modality. The patches were
cropped around the lymph node center and resampled
into 51 × 51 pixels of 1.0-mm size. The three patches of
each modality included one slice centered at the lymph
node center and two others located 4 mm above and
below the lymph node center. Our parallel patch config-
uration was different from [25] which used orthogonal
patches of axial, coronal, and sagittal directions, because
we found that parallel patches resulted in higher AUCs
than the orthogonal patches.
To generate the patches, the center of each lymph
node was specified by the doctor. This was the only step
requiring user input. To cope with the subjective vari-
ance of the user input, as well as to expand the size of
the training set, data augmentation was performed for
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the training data. The image patches were translated and
rotated in 3D space around the lymph node center to
generate more pseudo training patches. Each patch was
translated along x, y, and z axes by Nt steps and rotated
about the three axes by Nr angles. In this study, the
translation steps were [−2,0,2] pixels and the rotation
angles were [−20°,0°,20°], i.e., Nt =Nr = 3. As a result,
each sample was extended to Nt ×Nt ×Nt ×Nr ×Nr ×Nr
= 36 = 729 samples after data augmentation; hence, the
total sample size was 1397 × 729 = 1,018,413. Such data
augmentation strategy was commonly used by the deep
learning methods.
To train the network, the momentum update method
[35] was used, with batch size of 64 and momentum
coefficient of 0.9. The initial learning rate η was 1e−9, with
a decreasing rate γ = 0.9 for each iteration. After 10
epochs, η decreased to a very small value close to 0, and
the learning process converged to a local minima, which
might not be the global minima. To step out of the local
minima, we reactivated the learning process by setting η
back to a larger value (η= 1e−11), then continue the learn-
ing with γ= 0.95 until convergence. We found such reactiva-
tion scheme essential for obtaining good CNN performance.
Input features for classical methods
In this study, the input features for the classical methods
included 13 diagnostic features and 82 texture features.
Please note that these features are only used for the classical
methods, because CNN does not take the features as input.
Definitions of the features are listed in Table 2. The
term “diagnostic feature” is to represent the features
used by human doctors for clinical diagnosis, such as
tumor size, SUV, CT values, and image contrast. In
Table 2, the features of Dshort, area, and volume are
related to lymph node size, CTmean corresponds to tissue
density, and SUVmean and SUVmax represent lymph node
metabolism level. CTcontrast is used to measure the
density difference between the lymph node and its vicin-
ity, since metastatic tumor tends to merge with its
surrounding tissue. SUVstd measures the variation of
metabolism level inside the lymph node, because some
malignant tumors may have necrotic cores. For the features
of CTmean, CTcontrast, SUVmean, SUVmax, and SUVstd, both
2D and 3D versions were calculated. 2D versions were
calculated based on the axial slice passing the lymph node
center, and 3D versions were computed based on the
reconstructed volumes. We incorporated the 3D features to
compensate for the limitation of the doctors’ visual inspec-
tion of planar images.
To calculate the 95 features, manual segmentation of
the lymph nodes was performed by two doctors for all
axial slices covering the entire node. The lymph nodes
were delineated based on the fusion of PET and CT im-
ages because the two modalities compensated each other
Table 2 The image features used in this study. For the column of “image modality”, the term “PET/CT” means the feature is calculated
for both PET and CT
Feature Image modality Spatial dimension Definition
Dshort PET/CT 1D Diagnostic feature, maximum short diameter
of the axial section
Area PET/CT 2D Diagnostic feature, area of the axial section
Volume PET/CT 3D Diagnostic feature, volume of the lymph node
CTmean CT 2D/3D Diagnostic feature, mean CT value inside the
lymph node
CTcontrast CT 2D/3D Diagnostic feature, the difference between CTmean
and the mean CT value of a 2-mm-thick tissue layer
surrounding the lymph node.
SUVmean PET 2D/3D Diagnostic feature, mean SUV inside the lymph node
SUVmax PET 2D/3D Diagnostic feature, max SUV inside the lymph node
SUVstd PET 2D/3D Diagnostic feature, standard deviation of SUV inside
the lymph node
1st-order texture features PET/CT 3D Six texture features calculated based on the pixel
intensity histogram, see the supplementary material
of [22] for detailed definition
2nd-order texture features PET/CT 2D Nineteen texture features calculated based on gray-level
co-occurrence matrix (GLCM), see the supplementary material
of [22] for detailed definition
High-order texture features PET/CT 3D Five texture features calculated based on neighborhood
gray-tone difference matrix (NGTDM) and 11 texture features
calculated based on gray-level zone size matrix (GLZSM), see
the supplementary material of [22] for detailed definition
For the column of “spatial dimension”, the term “2D/3D” means the feature is calculated for both 2D and 3D images
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for defining fuzzy boundaries. To reduce inter-rater vari-
ance, the final segmentation was proofread by a doctor
with over 10 years experience. From the segmented
slices, 3D volumes of lymph nodes were reconstructed.
The texture features were calculated following the
instructions of a recent survey of PET/CT image
characterization [22]. The texture features included 5
first-order features based on histogram analysis, 19
second-order features based on gray-level co-occurrence
matrix (GLCM), and 16 high-order features based on
neighborhood gray-tone difference matrix (NGTDM)
and gray-level zone size matrix (GLZSM). The same
texture features were calculated for both PET and CT,
with 41 features for each modality. To avoid implemen-
tation variance, we used the publicly available code
provided by the authors of [22]. Before texture calculation,
the images were resampled to 1.0 × 1.0 × 1.0 mm3 iso-
tropic voxel size. Different parameter values for calculat-
ing texture features were tested, the optimal values were
selected by maximizing the AUC result. We used 64 bins
for both PET and CT images, within CT HU range [−300,
1000] and PET SUV range [0, 20]. The pixel distances
were 1 pixel, since most of the lymph nodes had a diam-
eter shorter than 4 mm. The GLCM was calculated in 3D
space, and the average matrix of all 13 neighborhood
directions were used to calculate the features.
For comparison purpose, we subdivided the 95
features into four sets, i.e., D13 (13 diagnostic features),
T82 (82 textural features), A95 (the combination of all
95 features), and S6 (6 selected features from A95). S6
was derived using the sequential forward feature selec-
tion method as in. The feature selection strategy was fre-
quently used for classical machine learning methods like
SVM to reduce the feature set and to improve classifica-
tion accuracy. The four feature sets will be compared for
each classical method.
Validation strategy
For method validation, a nested cross-validation (CV)
was performed. We used the outer CV loop to train and
test the machine learning methods and used the inner
CV loop to tune the method parameters. The outer loop
contained 10 times 10-fold cross-validation, and the
inner loop contained ninefold cross-validation using the
training samples of the outer loop, a grid search was
conducted to derive the optimal parameters for each
method. To keep the balance between the positive and
negative samples, 120 positive and 120 negative samples
were randomly selected for each cross-validation. The
CV was conducted on a per-node basis, so that different
folds did not contain samples from the same lymph
node. However, such strategy may assign different lymph
nodes of the same patient to different folds. When this
happened, the samples were exchanged between the
folds so that all the samples of one patient only exist in
one fold. In this way, we ensured the training and testing
data do not contain samples from the same lymph node
or the same patient, meanwhile keeping a balanced
number of positive and negative samples in each fold.
For fair comparison, different machine learning methods
were trained with the same training sets and tested with
the same testing sets.
For each cross-validation, we calculated the perform-
ance values for the five machine learning methods and
the doctors. The performance values include sensitivity
(SEN), specificity (SPC), diagnostic accuracy (ACC), and
the area under the receiver operating characteristic
(ROC) curve (AUC). The corresponding pathology ana-
lysis results were deemed as gold standard. The SEN,
SPC, and ACC values were determined from the optimal
cut point of the ROC curve, i.e., the point closest to
(0,1). The doctors’ performance was also evaluated using
the same criterion. Because doctors only made binary
diagnosis (positive or negative), no AUC could be calcu-
lated for human doctors.
Comparison between different feature sets and different
methods was mainly performed based on the AUC and
ACC values. Because the doctors do not have AUC re-
sults, the comparison between doctors and machine learn-
ing methods was only based on the ACC values. Due to
the 10 times 10-fold CV, 100 groups of performance
values were calculated for each feature set and each
method; therefore, paired hypothesis tests of 100 samples
were performed. The p values were calculated using
paired t test if the samples were normally distributed;
otherwise, the Wilcoxon-signed rank test was used. Mul-
tiple comparison correction strategies were applied to
limit the accumulation of false positives of multiple tests.
We applied two types of widely used correction strategies,
i.e., the Bonferroni correction which controls false posi-
tives but potentially increases false negatives and the false
discovery rate (FDR) correction (at q = 0.05) which gener-
ates less false negatives at the cost of increased false
positives than the Bonferroni correction. The null hypoth-
eses were rejected at the level of p < 0.05 after correction.
We firstly compared the four feature sets (D13, T82,
A95, and S6) for each classical method and selected the
optimal feature set with the highest mean AUC across
100 CVs. Afterwards, the classical methods with their
optimal feature sets were compared with CNN and
human doctors.
Results
Table 3 reports the performance values of the machine
learning methods and human doctors. For the four clas-
sical methods, the results of each feature set are also
listed. All the performance values are listed as the means
and standard deviations of the 100 cross-validations.
Wang et al. EJNMMI Research  (2017) 7:11 Page 5 of 11
Feature comparison
The optimal feature set of each classical method was se-
lected according to the AUC and ACC values. Figure 1
plots the AUC and ACC values of different feature sets
of each method. As shown by Table 3 and Fig. 1, D13 is
the optimal feature set of each classical method, while
T82 is the worst one. For RF, SVM, and AdaBoost, T82
yields lower AUC and ACC than any other feature set
Table 3 Performance values of the machine learning methods and human doctors
For each classical method, the results of each feature set are listed. The row of best feature set is marked with gray background
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(p < 0.05 after both Bonferroni and FDR corrections).
For most cases, the differences are not evident between
D13, A95, and S6, except for A95 vs. D6 for SVM ACC.
However, for BP-ANN, the AUC and ACC of A95 is as
low as T82, implying that adding T82 to D13 dramatic-
ally deteriorates the performance of BP-ANN. Compar-
ing the four classical methods based on each feature set,
AdaBoost, SVM, and RF are better than BP-ANN, while
the difference between AdaBoost, SVM, and RF is not
evident. These findings agree with a comprehensive
study [36] of different classical machine learning
methods for quantitative radiomic biomarkers.
Method comparison
Since D13 is the optimal feature set for all classical
methods, we used the performance values of D13 to
compare the classical methods with CNN and human
doctors. Figure 2 displays the mean values and confiden-
tial intervals of AUC and ACC of each method. It could
be observed that AdaBoost is the method of the highest
AUC, and CNN is the method of the highest ACC. BP-
ANN is the method of the lowest AUC and ACC, and it
is worse than any other method in terms of AUC. The
differences of AUC between BP-ANN and all other
methods were significant (p < 0.05) after FDR correction.
After the Bonferroni correction, the differences were
only significant between BP-ANN and RF and between
SVM and AdaBoost. SVM demonstrates no evident dif-
ferences with RF, AdaBoost, and CNN in terms of AUC
and ACC. Compared to ANN, SVM’s AUC value is sig-
nificantly higher (p < 0.05 after both Bonferroni and FDR
corrections), while the ACC value is higher but not
significant.
Because human doctors do not have AUC results, we
only compared the doctors with machine learning
methods based on ACC. Figure 2 indicates that CNN,
RF, and AdaBoost have better ACC than the doctors, but
the differences were not significant after the Bonferroni
Fig. 1 Comparison between different feature sets of the four classical machine learning methods, based on mean AUCs and mean ACCs of the
10 times 10-fold cross-validation. The error bars indicate 95% confidence interval. The p value between different feature sets are plotted as bridge
and stars, where two stars means p < 0.05 after both Bonferroni and FDR corrections, and one star means p < 0.05 only after FDR correction
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and FDR corrections. The p value between CNN and
human was less than 0.05 before correction; however, it
did not survive the FDR or Bonferroni correction. To
make further comparison, the ROC curves of all ma-
chine learning methods are plotted in Fig. 3, together
with the performance point of human doctors. The ROC
curve of each method is plotted as the average curve of
100 cross-validations. As revealed by Fig. 3, at the sensi-
tivity level of human doctors, CNN, RF, and AdaBoost
have better specificity than the doctors, and SVM has
close specificity to the doctors. However, when higher
sensitivity or higher specificity is considered, SVM
quickly catches up with CNN, RF, and AdaBoost. In con-
trast, the curve of BP-ANN is always below others.
Comparing the timing performance of the five
methods, SVM is the fastest, it took ~3 s to train for
each fold based on a A95 feature set, using a computer
with 2.2 GHz dual core i7 CPU. For the same training
data, RF and AdaBoost took ~6 and ~40 s, respectively.
BP-ANN took ~1 h to train using a CPU or ~2 min to
train using a GPU acceleration based on NVIDIA
Quadro K1100M graphics card. CNN was trained with
the GPU acceleration on a workstation with 449 G RAM
and NVIDIA Tesla K40C graphics card; it took ~10 min
for each fold of training. For testing, all the methods
took less than 1 s for a single cross-validation.
Discussion
Feature comparison
In recent years, an increasing number of publications
were using PET/CT texture features for tumor classifica-
tion. On the other side, some studies claim that texture
features are not reliable because their values are influ-
enced by factors irrelative to the tumor’s genuine property,
such as tumor size and image processing procedures [21].
In this study, we made efforts to follow the suggested
workflow of texture feature calculation by a recent review
study [22] and used their published code to avoid imple-
mentation bias. However, texture features still performed
significantly worse than the diagnostic features. The main
Fig. 2 Comparison between different machine learning methods and the human doctors, based on mean AUCs and mean ACCs of the 10 times
10-fold cross-validation. The error bars indicate 95% confidence interval. The p value between different methods are plotted as bridge and stars,
where two stars means p < 0.05 after both Bonferroni and FDR corrections, and one star means p < 0.05 only after FDR correction. Human doctor
has no AUC value
Fig. 3 The average ROC curves of different machine learning
methods. The black dot is the performance point of human doctors
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reason for the unsatisfactory performance of texture
features might be the small sizes of the lymph nodes.
According to Table 1, 80.3% of the tested lymph nodes
had a short axis diameter less than 4 mm. Small tumor
size means insufficient number of voxels for meaningful
heterogeneity measurement; therefore, the discrimina-
tive power of the texture features was compromised.
Because such small-sized lymph nodes dominate in a
clinical scenario, texture features might not be suit-
able for classifying a small size mediastinal lymph
node from PET/CT images.
Method comparison
As shown by the comparison of classical results,
AdaBoost, RF, and SVM performed better than ANN in
terms of both AUC and ACC. From a methodology as-
pect, AdaBoost and RF are both ensembles of decision
trees. We found that some other comparison studies
[36, 37] also demonstrated that ensemble methods out-
perform other classifiers. The mechanism of a decision
tree can utilize different features to compensate each
other, and the ensemble of decision trees combines mul-
tiple weak tree classifiers into a strong classifier. As a
result, the ensembles of decision trees can yield good
classification results based on an even weak feature set.
As shown by Table 3 and Fig. 1, when only T82 was
used as input features, AdaBoost and RF yielded better
AUC and ACC than SVM and BP-ANN. SVM belongs
to the kernel-based classifier family, which implicitly
maps the input features into a higher dimensional fea-
ture space using a kernel function that measures the dis-
tance between feature points in the mapped space. By
such kernel-based mapping, SVM is able to achieve
much better classification performance than conven-
tional linear classification methods. The choice of kernel
function greatly affects the performance of SVM, and
the nonlinear kernel function used in this study helped
SVM to maintain good performance even with subopti-
mal input features (A95 and S6).
ANN and CNN both belong to the neural networks
family, but ANN performed worse than CNN. We only
used two hidden layers for ANN; it seems that the im-
perfect performance of ANN might be due to the insuffi-
cient number of layers. However, as we tested different
layer numbers (from one hidden layer to seven hidden
layers), the best number was two instead of seven.
Although it is generally assumed that deeper networks
perform better than shallower ones, such assumption is
valid when there is enough training data, while the train-
ing method should also be good at learning deep net-
works. In this study, the training data of BP-ANN is not
abundant enough to support a deeper ANN, and the
back-propagation method is not suitable for training
deep networks [33]. In contrast, CNN is well designed
for learning deep networks, and it also uses data aug-
mentation to increase the training set.
Compared with human doctors from our institute, all
the five machine learning methods had higher sensitivity
but lower specificity than human doctors. Doctors
tended to underestimate the malignant tumors because
most of the lymph nodes in this study were small in size.
The machine learning methods gained better sensitivities
than human doctors at the cost of losing specificities.
When ACC was used as more balanced criteria than
sensitivity and specificity, RF, AdaBoost, and CNN were
better than human doctors, but the difference was not
significant after Bonferroni and FDR corrections.
In many recent publications of medical image analysis,
CNN was reported to outperform classical methods for
imaging modalities other than PET/CT. In this study,
CNN is not significantly better than RF, AdaBoost, or
SVM, because it has not fully explored the functional
nature of PET. Before the image patches are input to
CNN, the pixel intensities are normalized to a range of
[−1, 1], thus the discriminative power of SUV is lost dur-
ing the normalization. It was surprising to find that
without the important SUV feature, the difference
between CNN and the best classical methods is not evi-
dent. CNN utilizes the image appearance pattern around
the lymph node. The appearance pattern includes infor-
mation of local contrast, nearby tissues, boundary sharp-
ness, and etc. Such information is different from but as
powerful as the diagnostic features like SUV, tumor size,
and local heterogeneity. To illustrate the discriminative
power of the image appearance pattern, we extracted the
intermediate feature vector produced by the internal
flattening layer of the CNN. This was a vector of 512
features, which could be considered as a sparse repre-
sentation of the image patch’s appearance. We used the
512 features as the input of the classical methods. For
RF, the 512 features resulted in AUC and ACC of 0.89
and 80.8%, respectively. For SVM, the AUC and ACC
were 0.89 and 80.6%, respectively. These results were
much higher than the AUC and ACC of T82, and they
were even close to the results of D13. Unlike the texture
features, the appearance patterns of CNN are not
affected by the size of the lymph nodes, because they are
computed from the entire image patch which includes
both the lymph node and its surrounding tissues. There-
fore, the image appearance pattern can be a promising
substitute for the texture features, as well as a good
compensation to the diagnostic features.
This study used the AlexNet for CNN architecture,
but with a reduced number of layers. The reason for
using less neuron layers was to avoid overfitting to the
training data. Although we used 729 times data augmen-
tation, the total number of training data for each cross-
validation was still not abundant compared to many
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other deep learning applications. This was also the rea-
son that we did not use the more advanced CNN archi-
tectures like VGGNet [38], GoogleNet [39], and ResNet
[40] which were designed for a much larger training set.
In future work, if we can collect more data from multi-
centers, deeper CNN architectures will be explored.
Recently, there are some studies using a small set of
medical images to fine-tune the deep network learned
from a large natural image set, in order to solve the
problem of insufficient medical training data [41]. How-
ever, it is to be investigated if this method could perform
well on PET images, since the appearance of PET is
quite different from natural images.
In this study, image patches of both modalities (PET
and CT) were mixed into the same network. Such mixed
setting may potentially limit the performance of CNN,
because the PET and CT patches contained different
types of diagnostic information. It should be more ap-
propriate to process the PET and CT patches with sepa-
rated subnetworks and combine the results of different
subnetworks at the output layers. However, there is
currently no such architecture for dual-modality PET/CT
images, we will leave this issue for future research.
Conclusions
In conclusion, this study revealed that the diagnostic fea-
tures are more discriminative than the texture features,
mainly because the calculation of texture features is not
reliable due to the small lymph node size. CNN is a
recently popular method which utilizes image appear-
ance patterns for classification. In this study, the
performance of CNN is not significantly different from
the best classical methods, even though it did not use
the important diagnostic features like SUV and tumor
size. Moreover, CNN does not take hand-crafted features
as input, it eliminated the needs for tumor segmentation
and feature selection, making the whole process much
more convenient and less prone to user bias. CNN also
avoids using the debated texture features which are
affected by tumor size. Our future direction will focus
on improving the CNN performance by incorporating
diagnostic features into the network, as well as designing
more dedicated network structure for dual-modality
PET/CT images. This study was a single-center retro-
spective study. For the future, we are planning to collect
multi-center data to conduct more generalize evaluation,
as well as to explore the potential of deep learning with
more training data.
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